{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:16:33Z","timestamp":1792700193695,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autism spectrum disorders (ASD) are characterized by a wide genetic and clinical heterogeneity. However, some biochemical impairments, including decreased melatonin (crucial for circadian regulation) and elevated platelet N-acetylserotonin (the precursor of melatonin) have been reported as very frequent features in individuals with ASD. To address the mechanisms of these dysfunctions, we investigated melatonin synthesis in post-mortem pineal glands - the main source of melatonin (9 patients and 22 controls) - and gut samples - the main source of serotonin (11 patients and 13 controls), and in blood platelets from 239 individuals with ASD, their first-degree relatives and 278 controls. Our results elucidate the enzymatic mechanism for melatonin deficit in ASD, involving a reduction of both enzyme activities contributing to melatonin synthesis (AANAT and ASMT), observed in the pineal gland as well as in gut and platelets of patients. Further investigations suggest new, post-translational (reduced levels of 14-3-3 proteins which regulate AANAT and ASMT activities) and post-transcriptional (increased levels of miR-451, targeting 14-3-3\u03b6) mechanisms to these impairments. This study thus gives insights into the pathophysiological pathways involved in ASD.<\/jats:p>","DOI":"10.1038\/s41598-017-02152-x","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T11:05:29Z","timestamp":1494587129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders"],"prefix":"10.1038","volume":"7","author":[{"given":"C\u00e9cile","family":"Pagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Goubran-Botros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Benabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lemi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerren","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Amsellem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Callebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Chaste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Jamain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Fauchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Maronde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bourgeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"2152_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3992","volume":"16","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron, T. From the genetic architecture to synaptic plasticity in autism spectrum disorders. Nat. Rev. Neurosci. 16, 551\u2013563, doi:10.1038\/nrn3992 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"2152_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ridd.2005.03.003","volume":"27","author":"KS Lam","year":"2006","unstructured":"Lam, K. S., Aman, M. G. & Arnold, L. E. Neurochemical correlates of autistic disorder: a review of the literature. Res. Dev. Disabil. 27, 254\u2013289, doi:10.1016\/j.ridd.2005.03.003 (2006).","journal-title":"Res. Dev. Disabil."},{"key":"2152_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol, D. A. & Frye, R. E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17, 290\u2013314, doi:10.1038\/mp.2010.136 (2012).","journal-title":"Mol. Psychiatry"},{"key":"2152_CR4","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","volume":"52","author":"A Frustaci","year":"2012","unstructured":"Frustaci, A. et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic. Biol. Med. 52, 2128\u20132141, doi:10.1016\/j.freeradbiomed.2012.03.011 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"2152_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(61)80261-8","volume":"58","author":"RJ Schain","year":"1961","unstructured":"Schain, R. J. & Freedman, D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 58, 315\u2013320, doi:10.1016\/S0022-3476(61)80261-8 (1961).","journal-title":"J. Pediatr."},{"key":"2152_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1749-6632.1990.tb16893.x","volume":"600","author":"GM Anderson","year":"1990","unstructured":"Anderson, G. M., Horne, W. C., Chatterjee, D. & Cohen, D. J. The hyperserotonemia of autism. Ann. N. Y. Acad. Sci. 600, 331\u2013332, doi:10.1111\/nyas.1990.600.issue-1 (1990).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2152_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0006-3223(97)00532-5","volume":"45","author":"M Leboyer","year":"1999","unstructured":"Leboyer, M. et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol. Psychiatry 45, 158\u2013163, doi:10.1016\/S0006-3223(97)00532-5 (1999).","journal-title":"Biol. Psychiatry"},{"key":"2152_CR8","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1038\/tp.2014.120","volume":"4","author":"C Pagan","year":"2014","unstructured":"Pagan, C. et al. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl. Psychiatry 4, e479, doi:10.1038\/tp.2014.120 (2014).","journal-title":"Transl. Psychiatry"},{"key":"2152_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/BF02178193","volume":"25","author":"I Nir","year":"1995","unstructured":"Nir, I. et al. Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J. Autism Dev. Disord. 25, 641\u2013654, doi:10.1007\/BF02178193 (1995).","journal-title":"J. Autism Dev. Disord."},{"key":"2152_CR10","first-page":"31","volume":"21","author":"G Kulman","year":"2000","unstructured":"Kulman, G. et al. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinology Lett. 21, 31\u201334 (2000).","journal-title":"Neuroendocrinology Lett."},{"key":"2152_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biopsych.2004.11.003","volume":"57","author":"S Tordjman","year":"2005","unstructured":"Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H. & Touitou, Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol. Psychiatry 57, 134\u2013138, doi:10.1016\/j.biopsych.2004.11.003 (2005).","journal-title":"Biol. Psychiatry"},{"key":"2152_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.mp.4002016","volume":"13","author":"J Melke","year":"2008","unstructured":"Melke, J. et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 13, 90\u201398, doi:10.1038\/sj.mp.4002016 (2008).","journal-title":"Mol. Psychiatry"},{"key":"2152_CR13","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.psyneuen.2012.04.013","volume":"37","author":"S Tordjman","year":"2012","unstructured":"Tordjman, S. et al. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology 37, 1990\u20131997, doi:10.1016\/j.psyneuen.2012.04.013 (2012).","journal-title":"Psychoneuroendocrinology"},{"key":"2152_CR14","first-page":"187","volume":"36","author":"TC Erren","year":"2015","unstructured":"Erren, T. C. & Reiter, R. J. Melatonin: a universal time messenger. Neuroendocrinology Lett. 36, 187\u2013192 (2015).","journal-title":"Neuroendocrinology Lett."},{"key":"2152_CR15","doi-asserted-by":"publisher","first-page":"T187","DOI":"10.1530\/JOE-15-0119","volume":"226","author":"JD Johnston","year":"2015","unstructured":"Johnston, J. D. & Skene, D. J. Regulation of mammalian neuroendocrine physiology and rhythms by melatonin. J. Endocrinol. 226, T187\u2013T198, doi:10.1530\/JOE-15-0119 (2015).","journal-title":"J. Endocrinol."},{"key":"2152_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","volume":"9","author":"B Claustrat","year":"2005","unstructured":"Claustrat, B., Brun, J. & Chazot, G. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9, 11\u201324, doi:10.1016\/j.smrv.2004.08.001 (2005).","journal-title":"Sleep Med. Rev."},{"key":"2152_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1101\/sqb.2007.72.020","volume":"72","author":"T Bourgeron","year":"2007","unstructured":"Bourgeron, T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb. Symp. Quant. Biol. 72, 645\u2013654, doi:10.1101\/sqb.2007.72.020 (2007).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"2152_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0883073807309783","volume":"23","author":"IM Andersen","year":"2008","unstructured":"Andersen, I. M., Kaczmarska, J., Mc Grew, S. G. & Malow, B. A. Melatonin for insomnia in children with autism spectrum disorders. J. Child Neurol. 23, 482\u2013485, doi:10.1177\/0883073807309783 (2008).","journal-title":"J. Child Neurol."},{"key":"2152_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10803-010-1036-5","volume":"41","author":"B Wright","year":"2011","unstructured":"Wright, B. et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J. Autism Dev. Disord. 41, 175\u2013184, doi:10.1007\/s10803-010-1036-5 (2011).","journal-title":"J. Autism Dev. Disord."},{"key":"2152_CR20","doi-asserted-by":"crossref","unstructured":"Malow, B. et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J. Autism Dev. Disord. 42, 1729\u20131737; author reply 1738 (2012).","DOI":"10.1007\/s10803-011-1418-3"},{"key":"2152_CR21","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1073\/pnas.0912531107","volume":"107","author":"SW Jang","year":"2010","unstructured":"Jang, S. W. et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc. Natl. Acad. Sci. USA 107, 3876\u20133881, doi:10.1073\/pnas.0912531107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2152_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbr.2015.10.027","volume":"297","author":"A Choudhury","year":"2016","unstructured":"Choudhury, A., Singh, S., Palit, G., Shukla, S. & Ganguly, S. Administration of N-acetylserotonin and melatonin alleviate chronic ketamine-induced behavioural phenotype accompanying BDNF-independent and dependent converging cytoprotective mechanisms in the hippocampus. Behav. Brain Res. 297, 204\u2013212, doi:10.1016\/j.bbr.2015.10.027 (2016).","journal-title":"Behav. Brain Res."},{"key":"2152_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(01)00316-6","volume":"105","author":"T Obsil","year":"2001","unstructured":"Obsil, T., Ghirlando, R., Klein, D. C., Ganguly, S. & Dyda, F. Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell 105, 257\u2013267, doi:10.1016\/S0092-8674(01)00316-6 (2001).","journal-title":"Cell"},{"key":"2152_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-079X.2011.00880.x","volume":"51","author":"E Maronde","year":"2011","unstructured":"Maronde, E. et al. Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland. J. Pineal Res. 51, 145\u2013155, doi:10.1111\/j.1600-079X.2011.00880.x (2011).","journal-title":"J. Pineal Res."},{"key":"2152_CR25","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1101\/gad.1942110","volume":"24","author":"D Yu","year":"2010","unstructured":"Yu, D. et al. MiR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 24, 1620\u20131633, doi:10.1101\/gad.1942110 (2010).","journal-title":"Genes Dev."},{"key":"2152_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/onc.2011.223","volume":"31","author":"A Bergamaschi","year":"2012","unstructured":"Bergamaschi, A. & Katzenellenbogen, B. S. Tamoxifen downregulation of miR-451 increases 14-3-3\u03b6 and promotes breast cancer cell survival and endocrine resistance. Oncogene 31, 39\u201347, doi:10.1038\/onc.2011.223 (2012).","journal-title":"Oncogene"},{"key":"2152_CR27","doi-asserted-by":"publisher","first-page":"e70457","DOI":"10.1371\/journal.pone.0070457","volume":"8","author":"L Wu","year":"2013","unstructured":"Wu, L. et al. Altered expression of 14-3-3\u03b6 protein in spinal cords of rat fetuses with spina bifida aperta. PloS One 8, e70457, doi:10.1371\/journal.pone.0070457 (2013).","journal-title":"PloS One"},{"key":"2152_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1600-079X.2011.00902.x","volume":"51","author":"P Chaste","year":"2011","unstructured":"Chaste, P. et al. Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. J. Pineal Res 51, 394\u2013399, doi:10.1111\/jpi.2011.51.issue-4 (2011).","journal-title":"J. Pineal Res"},{"key":"2152_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1755-8794-3-10","volume":"3","author":"L Jonsson","year":"2010","unstructured":"Jonsson, L. et al. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med. Genomics 3, 10, doi:10.1186\/1755-8794-3-10 (2010).","journal-title":"BMC Med. Genomics"},{"key":"2152_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2350-12-17","volume":"12","author":"C Pagan","year":"2011","unstructured":"Pagan, C. et al. Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability. BMC Med. Genet. 12, 17, doi:10.1186\/1471-2350-12-17 (2011).","journal-title":"BMC Med. Genet."},{"key":"2152_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-079X.2012.01020.x","volume":"54","author":"H Goubran-Botros","year":"2013","unstructured":"Goubran-Botros, H. et al. Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway. J. Pineal Res. 54, 46\u201357, doi:10.1111\/j.1600-079X.2012.01020.x (2013).","journal-title":"J. Pineal Res."},{"key":"2152_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1755-8794-1-50","volume":"1","author":"G Cai","year":"2008","unstructured":"Cai, G. et al. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med. Genomics 1, 50, doi:10.1186\/1755-8794-1-50 (2008).","journal-title":"BMC Med. Genomics"},{"key":"2152_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/mp.2011.158","volume":"17","author":"PS Cheah","year":"2012","unstructured":"Cheah, P. S. et al. Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3\u03b6 deficiency. Mol. Psychiatry 17, 451\u2013466, doi:10.1038\/mp.2011.158 (2012).","journal-title":"Mol. Psychiatry"},{"key":"2152_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.drudis.2015.09.012","volume":"21","author":"Y Aghazadeh","year":"2016","unstructured":"Aghazadeh, Y. & Papadopoulos, V. The role of the 14-3-3 protein family in health, disease, and drug development. Drug Discovery Today 21, 278\u2013287, doi:10.1016\/j.drudis.2015.09.012 (2016).","journal-title":"Drug Discovery Today"},{"key":"2152_CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3565(25)29621-5","volume":"186","author":"JM Saavedra","year":"1973","unstructured":"Saavedra, J. M., Brownstein, M. & Axelrod, J. A specific and sensitive enzymatic-isotopic microassay for serotonin in tissues. J. Pharmacol. Exper. Ther 186, 508\u2013515 (1973).","journal-title":"J. Pharmacol. Exper. Ther"},{"key":"2152_CR36","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1073\/pnas.0406871102","volume":"102","author":"S Ganguly","year":"2005","unstructured":"Ganguly, S. et al. Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205. Proc. Natl. Acad. Sci. USA 102, 1222\u20131227, doi:10.1073\/pnas.0406871102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2152_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1600-079X.2005.00223.x","volume":"39","author":"T Liu","year":"2005","unstructured":"Liu, T. & Borjigin, J. N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night. J. Pineal Res. 39, 91\u201396, doi:10.1111\/jpi.2005.39.issue-1 (2005).","journal-title":"J. Pineal Res."},{"key":"2152_CR38","unstructured":"Launay, J. M., Barr\u00e9, N., Costa, J. L. & Da Prada, M. The melatonin pathway in blood platelets. Melatonin and the Pineal Gland. From Basic Science to Clinical Application. (eds Touitou, Y., Arendt, J. & P\u00e9vet, P.) 35\u201340 (Libbey, 1993)."},{"key":"2152_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1085\/jgp.201511526","volume":"147","author":"H Yu","year":"2015","unstructured":"Yu, H., Dickson, E. J., Jung, S. R., Koh, D. S. & Hille, B. High membrane permeability for melatonin. J. Gen. Physiol. 147, 63\u201376, doi:10.1085\/jgp.201511526 (2015).","journal-title":"J. Gen. Physiol."},{"key":"2152_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.mp.4002069","volume":"12","author":"C Toma","year":"2007","unstructured":"Toma, C. et al. Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations. Mol. Psychiatry 12, 977\u2013979, doi:10.1038\/sj.mp.4002069 (2007).","journal-title":"Mol. Psychiatry"},{"key":"2152_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10803-014-2197-4","volume":"45","author":"OJ Veatch","year":"2015","unstructured":"Veatch, O. J. et al. Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay. J. Autism Dev. Disord. 45, 100\u2013110, doi:10.1007\/s10803-014-2197-4 (2015).","journal-title":"J. Autism Dev. Disord."},{"key":"2152_CR42","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1093\/hmg\/dds227","volume":"21","author":"B Etain","year":"2012","unstructured":"Etain, B. et al. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum. Mol. Genet. 21, 4030\u20134037, doi:10.1093\/hmg\/dds227 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"2152_CR43","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/srep10232","volume":"5","author":"PA Geoffroy","year":"2015","unstructured":"Geoffroy, P. A. et al. Genetic association study of circadian genes with seasonal pattern in bipolar disorders. Sci. Rep 5, 10232, doi:10.1038\/srep10232 (2015).","journal-title":"Sci. Rep"},{"key":"2152_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-079X.2010.00754.x","volume":"48","author":"P Galecki","year":"2010","unstructured":"Galecki, P. et al. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder. J. Pineal Res. 48, 311\u2013317, doi:10.1111\/jpi.2010.48.issue-4 (2010).","journal-title":"J. Pineal Res."},{"key":"2152_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1740-3391-9-8","volume":"9","author":"DF Kripke","year":"2011","unstructured":"Kripke, D. F. et al. Polymorphisms in melatonin synthesis pathways: possible influences on depression. J. Circadian Rhythms 9, 8, doi:10.1186\/1740-3391-9-8 (2011).","journal-title":"J. Circadian Rhythms"},{"key":"2152_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0014-5793(87)81194-8","volume":"219","author":"T Ichimura","year":"1987","unstructured":"Ichimura, T., Isobe, T., Okuyama, T., Yamauchi, T. & Fujisawa, H. Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+,calmodulin-dependent protein kinase II. FEBS Lett. 219, 79\u201382, doi:10.1016\/0014-5793(87)81194-8 (1987).","journal-title":"FEBS Lett."},{"key":"2152_CR47","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/mp.2013.106","volume":"19","author":"C Toma","year":"2014","unstructured":"Toma, C. et al. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol. Psychiatry 19, 784\u2013790, doi:10.1038\/mp.2013.106 (2014).","journal-title":"Mol. Psychiatry"},{"key":"2152_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ajmg.b.32339","volume":"168B","author":"KK Jacobsen","year":"2015","unstructured":"Jacobsen, K. K., Kleppe, R., Johansson, S., Zayats, T. & Haavik, J. Epistatic and gene wide effects in YWHA and aromatic amino hydroxylase genes across ADHD and other common neuropsychiatric disorders: association with. YWHAE. Am. J. Med. Genet. part B 168B, 423\u2013432, doi:10.1002\/ajmg.b.32339 (2015).","journal-title":"YWHAE. Am. J. Med. Genet. part B"},{"key":"2152_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10110","volume":"474","author":"I Voineagu","year":"2011","unstructured":"Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380\u2013384, doi:10.1038\/nature10110 (2011).","journal-title":"Nature"},{"key":"2152_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ajhg.2014.03.018","volume":"94","author":"D Pinto","year":"2014","unstructured":"Pinto, D. et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Human. Genet. 94, 677\u201394, doi:10.1016\/j.ajhg.2014.03.018 (2014).","journal-title":"Am. J. Human. Genet."},{"key":"2152_CR51","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1210\/en.2006-0043","volume":"147","author":"K Ackermann","year":"2006","unstructured":"Ackermann, K. et al. Characterization of human melatonin synthesis using autoptic pineal tissue. Endocrinology 147, 3235\u20133242, doi:10.1210\/en.2006-0043 (2006).","journal-title":"Endocrinology"},{"key":"2152_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(93)90029-4","volume":"221","author":"IP Kema","year":"1993","unstructured":"Kema, I. P. et al. High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin. Chim. Acta 221, 143\u2013158, doi:10.1016\/0009-8981(93)90029-4 (1993).","journal-title":"Clin. Chim. Acta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02152-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:43:38Z","timestamp":1750254218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02152-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02152-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]},"assertion":[{"value":"25 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2096"}}